Anemia and Related Factors Among Highly Active Antiretroviral Therapy Experienced Children in Hawassa Comprehensive Specialized Hospital, Southern Ethiopia: Emphasis on Patient Management

References

• Davies M-A, Keiser O, Eley B, et al. Outcomes of the South African national antiretroviral treatment programme for children: the IeDEA Southern Africa collaboration. South Afr Med J. 2009;99(10):730–737.
   PubMed Web of Science ®Google Scholar
• Quaye W, Addai-Mensah A. Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011;11(1):2–15.21572851
   PubMed Web of Science ®Google Scholar
• Sliwa K. The multifactorial burden of anaemia in Africa. South Afr Med J. 2009;99(12):864–865.
   Web of Science ®Google Scholar
• WHO C. Worldwide Prevalence of Anaemia 1993–2005. WHO global database on anaemia; 2008.
   Google Scholar
• Quiros-Roldan E, Castelli F, Bonito A, et al. The impact of integrase inhibitor-based regimens on markers of inflammation among HIV naïve patients. Cytokine. 2020;126:154884. doi:10.1016/j.cyto.2019.15488431670006
   PubMed Web of Science ®Google Scholar
• Quiros-Roldan E, Castelli F, Lanza P, et al. The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia. J Transl Med. 2017;15(1):256. doi:10.1186/s12967-017-1358-629258550
   PubMed Web of Science ®Google Scholar
• Gedefaw L, Yemane T, Sahlemariam Z, Yilma D. Anemia and risk factors in HAART naive and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS One. 2013;8(8):e72202. doi:10.1371/journal.pone.007220223977253
   PubMed Web of Science ®Google Scholar
• Mata-Marín JA, Gaytán-Martínez JE, Martínez-Martínez RE, Arroyo-Anduiza CI, Fuentes-Allen JL, Casarrubias-Ramirez M. Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study. BMC Res Notes. 2010;3(1):230. doi:10.1186/1756-0500-3-23020727136
   PubMedGoogle Scholar
• Ruhinda EN, Bajunirwe F, Kiwanuka J. Anaemia in HIV-infected children: severity, types and effect on response to HAART. BMC Pediatr. 2012;12(1):170. doi:10.1186/1471-2431-12-17023114115
   PubMed Web of Science ®Google Scholar
• Walker AS, Doerholt K, Sharland M, Gibb DM. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. Aids. 2004;18(14):1915–1924. doi:10.1097/00002030-200409240-0000715353977
   PubMed Web of Science ®Google Scholar
• Calis JC, van Hensbroek MB, de Haan RJ, Moons P, Brabin BJ, Bates I. HIV-associated anemia in children: a systematic review from a global perspective. Aids. 2008;22(10):1099–1112. doi:10.1097/QAD.0b013e3282fa759f18525255
   PubMed Web of Science ®Google Scholar
• Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med. 2004;116(7):27–43. doi:10.1016/j.amjmed.2003.12.010
   Web of Science ®Google Scholar
• Musoke PM, Mudiope P, Barlow-Mosha LN, et al. Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study. BMC Pediatr. 2010;10(1):56. doi:10.1186/1471-2431-10-5620691045
   PubMed Web of Science ®Google Scholar
• Bunupuradah T, Kariminia A, Chan K-C, et al. Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy. Int J Infect Dis. 2013;17(10):e806–e810. doi:10.1016/j.ijid.2013.04.00623764352
   PubMed Web of Science ®Google Scholar
• Ejeliogu EU, Oguche S, Ebonyi AO, et al. Zidovudine-induced anaemia in human immunodeficiency virus infected children on highly active anti-retroviral therapy in Jos, Nigeria. J Adv Med Pharm Sci. 2014. doi:10.9734/JAMPS.
   Google Scholar
• Abebe M, Alemseged F. Hematologic abnormalities among children on Haart, in Jimma university specialized hospital, southwestern ethiopia. Ethiop J Health Sci. 2009;19(2).
   Google Scholar
• Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;38(10):1454–1463. doi:10.1086/38303115156485
   PubMed Web of Science ®Google Scholar
• Enawgaw B, Alem M, Melku M, Addis Z, Terefe B, Yitayew G. Prevalence and associated risk factors of anemia among HIV infected children attending Gondar university hospital, Northwest Ethiopia: a cross sectional study. BMC Hematol. 2015;15(1):12. doi:10.1186/s12878-015-0032-626413303
   PubMedGoogle Scholar
• Firnhaber C, Smeaton L, Saukila N, et al. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis. 2010;14(12):e1088–e1092. doi:10.1016/j.ijid.2010.08.00220961784
   PubMed Web of Science ®Google Scholar
• Mihiretie H, Taye B, Tsegaye A. Magnitude of anemia and associated factors among pediatric HIV/aids patients attending Zewditu memorial hospital art clinic, Addis Ababa, Ethiopia. Anemia. 2015;2015. doi:10.1155/2015/479329
   Google Scholar
• Teklemariam Z, Mitiku H, Mesfin F. Prevalence of anemia and nutritional status among HIV-positive children receiving antiretroviral therapy in Harar, eastern Ethiopa. HIV/AIDS. 2015;7:191.26089702
   PubMedGoogle Scholar
• Ahumareze RE, Rankin J, David A, et al. Prevalence of anaemia and the relationship between haemoglobin concentration and CD4 count in HIV positive children on highly active antiretroviral therapy (HAART) in Lagos, Nigeria. Curr Pediatr Res. 2016;20:29–36.
   Google Scholar
• Denue BA, Kida IM, Hammagabdo A, Dayar A, Sahabi MA. Prevalence of anemia and immunological markers in HIV-infected patients on highly active antiretroviral therapy in Northeastern Nigeria. Infect Dis. 2013;6:IDRT.S10477.
   Google Scholar
• Shet A, Bhavani P, Kumarasamy N, et al. Anemia, diet and therapeutic iron among children living with HIV: a prospective cohort study. BMC Pediatr. 2015;15(1):164. doi:10.1186/s12887-015-0484-726482352
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Bosch RJ, Kupka R, Hunter DJ, Msamanga GI, Fawzi WW. Predictors and consequences of anaemia among antiretroviral-naive HIV-infected and HIV-uninfected children in Tanzania. Public Health Nutr. 2010;13(2):289–296. doi:10.1017/S136898000999080219650963
   PubMed Web of Science ®Google Scholar
• Mengist HM, Taye B, Tsegaye A. Intestinal parasitosis in relation to CD4+ T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a model ART center in Addis Ababa, Ethiopia. PLoS One. 2015;10(2):e0117715. doi:10.1371/journal.pone.011771525658626
   PubMed Web of Science ®Google Scholar
• Ngongondo M, Rosenberg NE, Stanley CC, et al. Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study. BMC Infect Dis. 2018;18(1):39. doi:10.1186/s12879-018-2952-929334932
   PubMed Web of Science ®Google Scholar
• Shet A, Mehta S, Rajagopalan N, et al. Anemia and growth failure among HIV-infected children in India: a retrospective analysis. BMC Pediatr. 2009;9(1):37. doi:10.1186/1471-2431-9-3719531242
   PubMed Web of Science ®Google Scholar
• Shet A, Arumugam K, Rajagopalan N, et al. The prevalence and etiology of anemia among HIV-infected children in India. Eur J Pediatr. 2012;171(3):531–540. doi:10.1007/s00431-011-1599-y22009132
   PubMed Web of Science ®Google Scholar